Tomomi Shinke

Title: Tomomi Shinke: Innovator in Amyloid Detection Technologies

Introduction

Tomomi Shinke is a prominent inventor based in Hamamatsu, Japan. She has made significant contributions to the field of amyloid detection, focusing on innovative methods and devices that enhance the understanding of amyloid beta oligomers. With a total of 2 patents, her work is paving the way for advancements in medical diagnostics.

Latest Patents

Tomomi Shinke's latest patents include a method for detecting amyloid beta oligomers, an amyloid beta oligomer detection device, and an amyloid beta oligomer detection program. The detection method involves bringing a test sample into contact with thioflavin T, measuring the fluorescence to obtain time-resolved fluorescence spectra, and normalizing these spectra to confirm the presence of amyloid beta oligomers. Additionally, she has developed a method for purifying pure thioflavin T, which includes preparing a thioflavin T solution, contacting it with a non-polar polymeric porous body, and separating the solution after contact.

Career Highlights

Tomomi Shinke is currently employed at Hamamatsu Photonics K.K., where she continues to innovate in the field of optical technologies and medical diagnostics. Her work is characterized by a commitment to improving detection methods that can lead to better understanding and treatment of amyloid-related diseases.

Collaborations

Tomomi collaborates with notable colleagues, including Akinori Oda and Hiroshi Satozono, who contribute to her research and development efforts. Their teamwork enhances the potential for breakthroughs in amyloid detection technologies.

Conclusion

Tomomi Shinke's contributions to the field of amyloid detection are significant and impactful. Her innovative patents and collaborative efforts position her as a key figure in advancing medical diagnostics.